Microbix Biosystems Inc. (TSX:MBX)

Market Cap	30.54M
Revenue (ttm)	18.59M
Net Income (ttm)	-2.25M
Shares Out	138.81M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	577,461
Average Volume	86,523
Open	0.2250
Previous Close	0.2300
Day's Range	0.2150 - 0.2300
52-Week Range	0.2100 - 0.5500
Beta	0.43
RSI	36.98
Earnings Date	Feb 12, 2026

About Microbix Biosystems

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures a wide range of critical biological materials and medical devices for the global diagnostics industry, notably test ingredients (Antigen business) used in immunoassays, quality assessment, and diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for enabling the collection of p...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1988
• Employees: 70
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: MBX